STUDY SEARCH RESULTS

1 study found for your search request:  V110-911

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered with a Booster Dose of mRNA...
Condition: Pneumococcal infection
Minimum Age: 50 years, Maximum Age: N/A
Gender: All
Study ID: NCT05158140
Status: Completed
Has Results




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site